This grant from the National Institute on Drug Abuse aims to fund research focusing on synthetic psychoactive drugs, including their mechanisms of action, health effects, and the development of prevention and treatment strategies for patients in emergency departments. The grant supports projects that contribute to a better understanding of these substances and aim to mitigate their negative impacts on individuals. Researchers are encouraged to propose innovative approaches to tackle the challenges associated with synthetic psychoactive drugs. Application deadline: May 07, 2020.
Opportunity ID: 299508
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-527 |
| Funding Opportunity Title: | Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R03 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 18, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 07, 2020 |
| Current Closing Date for Applications: | May 07, 2020 |
| Archive Date: | Jun 12, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $50,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education County governments City or township governments State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Independent school districts Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to support research to deepen our knowledge of the use of synthetic psychoactive drugs, their mechanisms of action, their health effects, and development of prevention strategies and strategies to treat patients in emergency departments and long range treatment. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-527.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00237133 | Jan 16, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259675 | Jan 16, 2018 | May 07, 2020 | View |
Package 1
Mandatory forms
299508 RR_SF424_2_0-2.0.pdf
299508 PHS398_CoverPageSupplement_4_0-4.0.pdf
299508 RR_OtherProjectInfo_1_4-1.4.pdf
299508 PerformanceSite_2_0-2.0.pdf
299508 RR_KeyPersonExpanded_2_0-2.0.pdf
299508 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
299508 RR_Budget_1_4-1.4.pdf
299508 RR_SubawardBudget30_1_4-1.4.pdf
299508 PHS398_ModularBudget_1_2-1.2.pdf
299508 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
299508 RR_SF424_2_0-2.0.pdf
299508 PHS398_CoverPageSupplement_5_0-5.0.pdf
299508 RR_OtherProjectInfo_1_4-1.4.pdf
299508 PerformanceSite_2_0-2.0.pdf
299508 RR_KeyPersonExpanded_2_0-2.0.pdf
299508 PHS398_ResearchPlan_4_0-4.0.pdf
299508 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
299508 RR_Budget_1_4-1.4.pdf
299508 RR_SubawardBudget30_1_4-1.4.pdf
299508 PHS398_ModularBudget_1_2-1.2.pdf
299508 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
